(IN BRIEF) Boehringer Ingelheim has expanded its Detect the SOS mission globally to increase awareness and use of urine albumin-to-creatinine ratio testing among people living with hypertension, type 2 diabetes, or both. The company says uACR testing remains significantly underused … Read the full press release
